CTNNB1 and intestinal neoplasm: The discrepancy of R-spondin 1 dependence between tumorigenicity induced by the current method and previous GEMM relied on Apc depletion or CTNNB1 activation [4] is supported by the mutual exclusion of R-spondin fusion and Apc or CTNNB1 mutation identified in human intestinal tumors [20].